1. ImmunoGen Appoints Stuart A. Arbuckle to Board of Directors

    ImmunoGen Appoints Stuart A. Arbuckle to Board of Directors

    WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced the appointment of Stuart A. Arbuckle to its Board of Directors . Mr. Arbuckle is replacing Howard Pien, who is ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content

    1. We are grateful for Howard's many contributions to ImmunoGen over the last eight years.
    2. Stuart joins ImmunoGen's Board at a pivotal moment in the Company's evolution.
    3. ImmunoGen embarked on a journey last year to focus on its highest value programs and develop into a fully integrated biotech company. I'm delighted to offer my insights and work with this Board as ImmunoGen drives long-term value creation and moves towards commercializing its first product.
  3. Topics Mentioned